Raia Drogasil S.A.
RADLY
$2.86
-$0.319-10.05%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 1.73B | 1.80B | 1.86B | 1.84B | 1.80B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.73B | 1.80B | 1.86B | 1.84B | 1.80B |
| Cost of Revenue | 1.21B | 1.27B | 1.30B | 1.30B | 1.26B |
| Gross Profit | 511.08M | 535.78M | 562.60M | 537.16M | 542.56M |
| SG&A Expenses | 421.25M | 420.54M | 435.19M | 430.71M | 446.40M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 6.16M | 4.66M | 1.76M | 122.20K | -15.08M |
| Total Operating Expenses | 1.64B | 1.69B | 1.73B | 1.73B | 1.69B |
| Operating Income | 83.66M | 110.59M | 125.65M | 106.32M | 111.24M |
| Income Before Tax | 47.71M | 79.51M | 79.80M | 56.57M | 59.64M |
| Income Tax Expenses | -11.84M | 18.35M | 16.74M | 17.52M | 3.45M |
| Earnings from Continuing Operations | 59.55M | 61.16M | 63.07M | 39.05M | 56.18M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 20.70K | -739.90K | -391.60K | -1.11M | -3.48M |
| Net Income | 59.57M | 60.42M | 62.67M | 37.94M | 52.70M |
| EBIT | 83.66M | 110.59M | 125.65M | 106.32M | 111.24M |
| EBITDA | 115.04M | 142.53M | 159.22M | 140.77M | 144.90M |
| EPS Basic | 0.04 | 0.04 | 0.02 | 0.02 | 0.03 |
| Normalized Basic EPS | 0.02 | 0.03 | 0.02 | 0.02 | 0.02 |
| EPS Diluted | 0.04 | 0.04 | 0.02 | 0.02 | 0.03 |
| Normalized Diluted EPS | 0.02 | 0.03 | 0.02 | 0.02 | 0.02 |
| Average Basic Shares Outstanding | 1.65B | 1.65B | 2.87B | 1.65B | 1.72B |
| Average Diluted Shares Outstanding | 1.65B | 1.66B | 2.87B | 1.67B | 1.72B |
| Dividend Per Share | -- | 0.02 | -- | -- | 0.04 |
| Payout Ratio | 67.74% | 0.33% | 72.67% | 0.10% | 91.65% |
